Jan 6 (Reuters) - Nimbus Therapeutics said on Tuesday it has entered into a multi-year research and licensing agreement with Eli Lilly (LLY.N), opens new tab to develop artificial intelligence-driven ...
Eli Lilly LLY-2.19%decrease; red down pointing triangle and Nimbus Therapeutics have entered into a multi-year collaboration and exclusive licensing agreement to develop an oral treatment for obesity ...
Privately owned drug discovery company Nimbus Therapeutics on Tuesday announced that it expanded its research collaboration with Eli Lilly (LLY) to develop an oral obesity therapy in a deal worth up ...
Boston biotech Nimbus Therapeutics is teaming up with Eli Lilly & Co. to develop a new oral obesity treatment in a deal worth up to $1.3 billion, the company announced Tuesday. It’s the latest move in ...
Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of oral obesity therapies. The latest partnership will see Lilly pass ...
Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines through its AI-enhanced computational drug discovery engine, today announced it ...
For a second time, Eli Lilly has turned to Boston biotech Nimbus Therapeutics to add a potential weight loss therapy to its pipeline. The latest agreement, which could be worth upwards of $1.3 billion ...
Nimbus and Eli Lilly collaborate to develop oral treatments for obesity and metabolic diseases, leveraging Nimbus' computational drug design and Lilly's metabolic expertise. The agreement includes $55 ...
BOSTON, January 06, 2026--(BUSINESS WIRE)--Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a drug discovery company developing breakthrough medicines through its AI-enhanced ...
Nimbus and Eli Lilly collaborate to develop an oral treatment for obesity, leveraging computational chemistry and structure-based drug design. The partnership builds on previous efforts targeting AMPK ...
ASICS has officially unveiled the 28th generation of its legendary GEL-NIMBUS neutral running shoe, and preorder is already open ahead of the January 9, 2026 release date. The Nimbus series has been a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results